Review Papers | Medicine | India | Volume 10 Issue 6, June 2021
Overview on Remdesivir
Sahil Surendrakumar Shambharkar
Abstract: Remdesiviris a broad range anti viral drug primarily discovered for the treatment for hepatitis C and respiratory syncytial virus (RSV), later used in the treatment of ebola and now is being used in the treatment of covid-spectrum antiviral agent that has previously demonstrated antiviral activity against filoviruses (ebola viruses, marburgvirus), coronaviruses (SARS-COV, MERS-CO-V, SARS-COV-2), paramyxoviruses (parainfluenza type iii virus, nipah virus, hendra virus, measles, and mumps virus), and pnemoviridae (respiratory syncytial virus).
Keywords: remdesivir, GS-441524, SARS-COV-2, COVID-19, nucleoside triphosphate, RNA dependant RNA polymerase, ebola
Edition: Volume 10 Issue 6, June 2021,
Pages: 1344 - 1349
How to Cite this Article?
Sahil Surendrakumar Shambharkar, "Overview on Remdesivir", International Journal of Science and Research (IJSR), https://www.ijsr.net/get_abstract.php?paper_id=MR21620233610, Volume 10 Issue 6, June 2021, 1344 - 1349
How to Share this Article?